Northstar Asset Management LLC trimmed its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 6.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,270 shares of the medical research company’s stock after selling 2,160 shares during the quarter. Thermo Fisher Scientific comprises about 2.8% of Northstar Asset Management LLC’s portfolio, making the stock its 6th biggest position. Northstar Asset Management LLC’s holdings in Thermo Fisher Scientific were worth $6,295,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. Liberty Capital Management Inc. grew its holdings in shares of Thermo Fisher Scientific by 2.1% in the third quarter. Liberty Capital Management Inc. now owns 19,579 shares of the medical research company’s stock valued at $3,795,000 after acquiring an additional 411 shares in the last quarter. North Star Asset Management Inc. grew its holdings in Thermo Fisher Scientific by 2.4% during the third quarter. North Star Asset Management Inc. now owns 48,571 shares of the medical research company’s stock valued at $7,461,000 after purchasing an additional 1,126 shares during the period. State of New Jersey Common Pension Fund D grew its holdings in Thermo Fisher Scientific by 11.8% during the third quarter. State of New Jersey Common Pension Fund D now owns 95,000 shares of the medical research company’s stock valued at $17,974,000 after purchasing an additional 10,000 shares during the period. Aperio Group LLC grew its holdings in Thermo Fisher Scientific by 9.9% during the third quarter. Aperio Group LLC now owns 345,539 shares of the medical research company’s stock valued at $65,376,000 after purchasing an additional 31,185 shares during the period. Finally, Trust Co. of Vermont grew its holdings in Thermo Fisher Scientific by 1.2% during the third quarter. Trust Co. of Vermont now owns 37,685 shares of the medical research company’s stock valued at $7,130,000 after purchasing an additional 450 shares during the period. 86.16% of the stock is currently owned by institutional investors.
Shares of Thermo Fisher Scientific Inc (NYSE:TMO) traded down $10.17 during midday trading on Monday, reaching $182.03. 3,926,780 shares of the company were exchanged, compared to its average volume of 1,555,471. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26. Thermo Fisher Scientific Inc has a 52 week low of $139.88 and a 52 week high of $201.20. The stock has a market cap of $72,610.00, a price-to-earnings ratio of 21.12, a P/E/G ratio of 1.76 and a beta of 1.06.
Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The business had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter in the previous year, the firm posted $2.03 EPS. The firm’s revenue was up 13.9% on a year-over-year basis. equities research analysts predict that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is 10.19%.
Several equities research analysts have issued reports on the company. Deutsche Bank set a $226.00 target price on Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, October 26th. Zacks Investment Research downgraded Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Tuesday, September 12th. Leerink Swann increased their price objective on Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a research report on Monday, October 9th. Finally, Cowen restated an “outperform” rating and set a $220.00 price target (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. One research analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company. Thermo Fisher Scientific has a consensus rating of “Buy” and an average price target of $205.21.
In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the sale, the chief executive officer now owns 252,577 shares in the company, valued at approximately $47,582,981.03. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Peter E. Hornstra sold 3,894 shares of the business’s stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total transaction of $721,090.92. Following the completion of the sale, the vice president now owns 19,751 shares in the company, valued at approximately $3,657,490.18. The disclosure for this sale can be found here. Corporate insiders own 0.49% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Thermo Fisher Scientific Inc (TMO) Shares Sold by Northstar Asset Management LLC” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.dispatchtribunal.com/2017/12/04/thermo-fisher-scientific-inc-tmo-is-northstar-asset-management-llcs-6th-largest-position.html.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.